How is remedial second liver vaccine to return a responsibility

Update Date: 2025-01-18 Source: Network

summary

As we all know, hepatitis B is a serious disease, which is not only difficult to treat, but also infectious. If it is not cured for a long time, it will not only aggravate the disease itself, but also infect the people around it. Therefore, there is a new method of hepatitis B treatment, namely therapeutic hepatitis B vaccine. So how is therapeutic hepatitis B vaccine going on? Now let's introduce it to you.

How is remedial second liver vaccine to return a responsibility

First, therapeutic hepatitis B vaccine refers to the natural, synthetic or gene recombinant products or products that can treat or prevent the deterioration of the disease by inducing specific immune response in the body infected with pathogenic microorganisms or suffering from some diseases. Before 1995, it was generally believed that vaccines were only used to prevent diseases. With the development of immunology, people have found a new use of vaccine, that is, it can treat some refractory diseases. Since then, the vaccine has both preventive and therapeutic effects. Therapeutic hepatitis B vaccine belongs to specific active immunotherapy.

Second: the complete elimination of hepatitis B virus (HBV) infection, ultimately through the role of the body's immune system, but after HBV infection, through a series of mechanisms to inhibit the body's specific immune response. Therefore, it is necessary to elucidate the immune escape mechanism of HBV, develop new immunotherapy, further improve the curative effect and reduce the mortality. There are many institutions at home and abroad in the research of therapeutic hepatitis B vaccine.

Third: China has made some progress in research. Three scientific research institutions and four therapeutic hepatitis B vaccines have entered clinical trials.

matters needing attention

The treatment of hepatitis B is more difficult, but if we adhere to the scientific treatment, then there is still a great possibility of cure. As for therapeutic hepatitis B vaccine, it is still in the research stage and not mature, so we should think twice before using it.